In Treatment of Type 2 diabetes mellitus Q Repa 2mg Tablet increases the amount of insulin your body produces (in the pancreas). The insulin then works to lower your blood glucose levels and prevents them from rising after taking meals. You should keep taking it for as long as it is prescribed. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with Q Repa 2mg Tablet.
Q Repa 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Q Repa 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Q Repa 2mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Q Repa 2mg Tablet may be needed. Please consult your doctor.
Q Repa 2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Q Repa 2mg Tablet may be needed. Please consult your doctor. Use of Q Repa 2mg Tablet is not recommended in patients with severe liver disease.
If you miss a dose of Q Repa 2mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Shinto Organics (P) Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Eris Lifesciences Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Daylon Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Icon Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mcronus Lifescience Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Klintoz Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Shilpex Pharmysis || ₹14.5/tablet (25% cheaper)